Kallikrein 8 Antikörper (AA 87-241)

Produktnummer ABIN7157221

Produktdetails anti-Kallikrein 8 Antikörper

Target: Kallikrein 8 (KLK8)

Bindungsspezifität: AA 87-241

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Kallikrein 8 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Kallikrein-8 protein (87-241AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu Kallikrein 8

Target: Kallikrein 8 (KLK8)

Andere Bezeichnung: KLK8 (KLK8 Produkte)

Synonyme: HNP antikoerper, NP antikoerper, NRPN antikoerper, PRSS19 antikoerper, TADG14 antikoerper, bsp1 antikoerper, KLK8 antikoerper, BSP1 antikoerper, Nrpn antikoerper, Prss19 antikoerper, kallikrein related peptidase 8 antikoerper, kallikrein related-peptidase 8 antikoerper, KLK8 antikoerper, Klk8 antikoerper

Hintergrund:

Background: Serine protease which is capable of degrading a number of proteins such as casein, fibrinogen, kininogen, fibronectin and collagen type IV. Also cleaves L1CAM in response to increased neural activity. Induces neurite outgrowth and fasciculation of cultured hippocampal neurons. Plays a role in the formation and maturation of orphan and small synaptic boutons in the Schaffer-collateral pathway, regulates Schaffer-collateral long-term potentiation in the hippocampus and is required for memory acquisition and synaptic plasticity. Involved in skin desquamation and keratinocyte proliferation. Plays a role in the secondary phase of pathogenesis following spinal cord injury.

Aliases: Brain serine protease 1 antibody, BSP1 antibody, hK8 antibody, HNP antibody, HPN antibody, Kallikrein 8 (neuropsin/ovasin) antibody, Kallikrein related peptidase 8 antibody, Kallikrein-8 antibody, Kallikrein8 antibody, KLK 8 antibody, Klk8 antibody, KLK8 protein type 1 antibody, KLK8 protein type 2 antibody, KLK8_HUMAN antibody, Neuropsin antibody, neuropsin type 1 antibody, Neuropsin type 1, included antibody, Neuropsin type 2 antibody, Neuropsin type 2, included antibody, Neuropsin, mouse, homolog of antibody, NP antibody, NRPN antibody, Ovasin antibody, PRO322 antibody, Protease serine 19 antibody, PRSS 19 antibody, PRSS19 antibody, Serine protease 19 antibody, Serine protease kallikrein antibody, Serine protease kallikrein/ovasin/neuropsin antibody, Serine protease TADG 14 antibody, Serine protease TADG-14 antibody, Serine protease TADG14 antibody, TADG 14 antibody, TADG14 antibody, Tumor associated differentially expressed gene 14 antibody, Tumor associated differentially expressed gene 14 protein antibody, Tumor-associated differentially expressed gene 14 protein antibody, UNQ283 antibody

UniProt: O60259

Pathways: Komplementsystem